Davide Brogi

499 total citations
3 papers, 127 citations indexed

About

Davide Brogi is a scholar working on Pathology and Forensic Medicine, Molecular Biology and Neurology. According to data from OpenAlex, Davide Brogi has authored 3 papers receiving a total of 127 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pathology and Forensic Medicine, 2 papers in Molecular Biology and 1 paper in Neurology. Recurrent topics in Davide Brogi's work include Multiple Sclerosis Research Studies (3 papers), Sphingolipid Metabolism and Signaling (2 papers) and T-cell and B-cell Immunology (1 paper). Davide Brogi is often cited by papers focused on Multiple Sclerosis Research Studies (3 papers), Sphingolipid Metabolism and Signaling (2 papers) and T-cell and B-cell Immunology (1 paper). Davide Brogi collaborates with scholars based in Italy. Davide Brogi's co-authors include Antonio Uccelli, Gianluigi Mancardi, Gilberto Filaci, Francesca Kalli, Alessia Parodi, Laura D. Serpero, Florinda Battaglia, Daniela Fenoglio, Alice Laroni and Alessandra Lugaresi and has published in prestigious journals such as BMC Neurology, Journal of Neuroimmune Pharmacology and Neurological Sciences.

In The Last Decade

Davide Brogi

3 papers receiving 126 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Davide Brogi Italy 3 92 69 38 30 19 3 127
Arno Siever Germany 4 147 1.6× 87 1.3× 12 0.3× 50 1.7× 21 1.1× 5 177
Marco Ronzoni Italy 4 57 0.6× 31 0.4× 56 1.5× 12 0.4× 33 1.7× 8 139
Eric Hong United States 7 54 0.6× 45 0.7× 46 1.2× 4 0.1× 34 1.8× 9 151
Martina Finetti United Kingdom 3 32 0.3× 55 0.8× 5 0.1× 5 0.2× 13 0.7× 8 70
Edoardo Simonetti Italy 4 38 0.4× 19 0.3× 21 0.6× 11 0.4× 24 1.3× 9 65
Mark Freedman Canada 4 18 0.2× 14 0.2× 16 0.4× 6 0.2× 18 0.9× 11 48
D. S. Korobko Russia 5 32 0.3× 8 0.1× 11 0.3× 33 1.1× 12 0.6× 28 65
Jessica T. Cortez United States 6 7 0.1× 75 1.1× 62 1.6× 5 0.2× 19 1.0× 9 156
Alexander Waldrop United States 4 14 0.2× 28 0.4× 14 0.4× 7 0.2× 33 1.7× 5 75
Yong Bi China 7 7 0.1× 43 0.6× 20 0.5× 13 0.4× 12 0.6× 11 107

Countries citing papers authored by Davide Brogi

Since Specialization
Citations

This map shows the geographic impact of Davide Brogi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Davide Brogi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Davide Brogi more than expected).

Fields of papers citing papers by Davide Brogi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Davide Brogi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Davide Brogi. The network helps show where Davide Brogi may publish in the future.

Co-authorship network of co-authors of Davide Brogi

This figure shows the co-authorship network connecting the top 25 collaborators of Davide Brogi. A scholar is included among the top collaborators of Davide Brogi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Davide Brogi. Davide Brogi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

3 of 3 papers shown
1.
Laroni, Alice, Davide Brogi, Vincenzo Brescia Morra, et al.. (2016). Safety and tolerability of fingolimod in patients with relapsing-remitting multiple sclerosis: results of an open-label clinical trial in Italy. Neurological Sciences. 38(1). 53–59. 20 indexed citations
2.
Laroni, Alice, Davide Brogi, Vincenzo Brescia Morra, et al.. (2014). Safety of the first dose of fingolimod for multiple sclerosis: results of an open-label clinical trial. BMC Neurology. 14(1). 65–65. 44 indexed citations
3.
Serpero, Laura D., Gilberto Filaci, Alessia Parodi, et al.. (2013). Fingolimod Modulates Peripheral Effector and Regulatory T Cells in MS Patients. Journal of Neuroimmune Pharmacology. 8(5). 1106–1113. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026